Picture of ConvaTec logo

CTEC ConvaTec News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG - ConvaTec Group PLC - Director/PDMR Shareholding




 



RNS Number : 5102X
ConvaTec Group PLC
28 August 2020
 

28 August 2020

ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 25 August 2020, Heather Mason, Non-Executive Director and PDMR, purchased 10,000 Shares at £1.978688 per share. Ms Mason's resulting shareholding is 10,000 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Heather Mason

2

Reason for the notification

a)

Position/Status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73

b)

Nature of the transaction

  Purchase of Shares on 8 January 2020

 

c)

Price(s) and volume(s)

Price(s)

£1.978688

Volume(s)

10,000

d)

Aggregated information

- Aggregated volume 

- Price

 

10,000

£19.786.88

e)

Date of the transaction

25 August 2020

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)






 

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations                                         +44 (0)7551 036 625

investorrelations@convatec.com

Media

Buchanan

                        +44 (0)207 466 5000

Charles Ryland/Chris Lane/Vicky Hayns


ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSTAITFII

Recent news on ConvaTec

See all news